The Associate Director/ Director of Health Economics and Outcomes Research (Early Stage Pipeline) will be responsible for defining and executing early evidence generation strategies and deliverables across multiple programs.
Support HEOR/COA endpoint strategy from Phase 1 to 3 clinical studies ensuring inclusion of patient-centric, clinically meaningful, and economically relevant outcomes.
Contribute to commercial and global market access strategy to influence trial designs that meet expectations from multiple stakeholders.
Lead development of HTA-grade cost-effectiveness and budget-impact models to support early decision-making, identify value drivers, pricing, value dossiers, and individual country-specific submissions.
Partner with Global/US Market Access and Regulatory to ensure pivotal studies capture relevant endpoints.

Advanced degree(s) in Health Economics, Outcomes Research, Economics, Health Services Research, Business or psychometrics.
Associate Director: 8+ years and a master’s degree; or a PhD with 5+ years’ experience in pharmaceutical, biotechnology, or HEOR consulting environments; rare disease or neurology/cardiometabolic experience preferred.
Director: 12+ years and a master’s degree; or a PhD with 8+ years’ experience in pharmaceutical, biotechnology, or HEOR consulting environments; rare disease or neurology/cardiometabolic experience preferred.
Excellent communicator with proven interpersonal skills and ability to influence R&D, Commercial, Medical, and Regulatory teams.
Strong scientific writing and oral presentation skills.
Travel expectation is 30%.

Associate Director/Director, Health Economics and Outcomes Research – Early Stage Pipeline

Key skills